PROVAYBLUE- methylene blue injection ABD - İngilizce - NLM (National Library of Medicine)

provayblue- methylene blue injection

cenexi hsc - methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - provayblue ® usp is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia. this indication is approved under accelerated approval. continued approval for this indication may be contingent upon verification of clinical benefit in subsequent trials [ see clinical studies ( 14.1) ]. provayblue ® is contraindicated in the following conditions: - severe hypersensitivity reactions to methylene blue or any other thiazine dye [see warnings and precautions ( 5.2)] . - patients with glucose-6-phosphate dehydrogenase deficiency (g6pd) due to the risk of hemolytic anemia [see warnings and precautions ( 5.3,

Lumeblue (previously known as Methylthioninium chloride Cosmo) Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - methylthioninium chloride - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.